Inactive Instrument
Aradigm Corporation Stock Nasdaq
Stocks
US0385054004
Biotechnology & Medical Research
OTC Markets Traded
| Market Cap | 4.89M 4.21M 3.88M 3.64M 6.83M 462M 6.91M 45.81M 17.85M 226M 18.33M 17.94M 784M | P/E Ratio 2016 |
-0.72x | P/E Ratio 2017 | -9.3x |
|---|---|---|---|---|---|
| Enterprise Value | 12.8M 11.03M 10.16M 9.54M 17.9M 1.21B 18.09M 120M 46.75M 593M 48.03M 47.01M 2.05B | EV / Sales 2016 |
73.3x | EV / Sales 2017 | 7.27x |
| Free-Float |
60.28% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +36.88% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +36.88% | +25.50% | - | - | 702K | |
| +0.85% | -0.34% | -11.16% | -9.42% | 43.51B | |
| -2.17% | +4.70% | +293.71% | +535.99% | 33.29B | |
| -1.60% | -1.58% | -0.19% | +31.82% | 29.34B | |
| +0.44% | -3.80% | +12.51% | -17.06% | 29.9B | |
| -0.29% | +2.65% | +13.24% | +21.04% | 25.42B | |
| +3.54% | +8.43% | - | - | 14.36B | |
| -1.26% | -1.11% | +53.37% | +108.10% | 13.18B | |
| -0.13% | -4.25% | +3.30% | +4.40% | 12.72B | |
| -1.18% | -2.00% | +107.41% | +78.18% | 12.08B | |
| Average | +3.50% | +1.20% | +59.02% | +94.13% | 23.76B | |
| Weighted average by Cap. | -0.28% | +1.24% | +60.37% | +104.37% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 195K 168K 155K 145K 273K 18.44M 276K 1.83M 712K 9.03M 732K 716K 31.29M | 14.46M 12.47M 11.48M 10.78M 20.24M 1.37B 20.45M 136M 52.84M 670M 54.29M 53.13M 2.32B |
| Net income | -32.94M -28.39M -26.14M -24.54M -46.08M -3.11B -46.56M -309M -120M -1.53B -124M -121M -5.28B | -10.7M -9.23M -8.5M -7.98M -14.98M -1.01B -15.13M -100M -39.11M -496M -40.17M -39.32M -1.72B |
| Net Debt | -9.37M -8.08M -7.44M -6.98M -13.11M -886M -13.25M -87.88M -34.24M -434M -35.17M -34.43M -1.5B | 7.91M 6.82M 6.28M 5.9M 11.07M 748M 11.19M 74.2M 28.91M 366M 29.7M 29.07M 1.27B |
Employees
-
